Chongqing Biocare Pharmaceutical Ltd, based in Turkey, is a pharmaceutical company.
One of their notable products is CLINDAMYCIN PALMITATE HYDROCHLORIDE USP, NON-STERILE, BULK DRUG, with a corresponding US DMF Number 23974.
Remarkably, this DMF maintains an Active status since its submission on July 06, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 10, 2014, and payment made on September 16, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II